FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2013, Issue , 2013, Pages 220-226

  Levis, Mark ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR;

ALLOGRAFT; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; GENETICS; HUMAN; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MUTATION; STEM CELL TRANSPLANTATION;

ALLOGRAFTS; FMS-LIKE TYROSINE KINASE 3; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; PROTEIN KINASE INHIBITORS; STEM CELL TRANSPLANTATION;

EID: 84899491662     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2013.1.220     Document Type: Review

References (0)